NCT06945445View on ClinicalTrials.gov

Study of SLN12140 in Healthy Adult Participants

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

June 30, 2026

Conditions
Healthy Volunteer
Interventions
DRUG

SLN12140

SLN12140 for sc injection or IV infusion

OTHER

Placebo

Placebo for sc injection or IV infusion

Trial Locations (3)

200040

Huashan Hospital, Shanghai

Phase I center of Fudan University Huashan Hospital, Shanghai

Unknown

Huashan Hospital, Shanghai

Sponsors
All Listed Sponsors
lead

Linno Pharmaceuticals, Inc.

INDUSTRY